↓ Skip to main content

Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance…

Overview of attention for article published in Arthritis Research & Therapy, May 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news
3 news outlets
twitter
16 X users
facebook
1 Facebook page

Citations

dimensions_citation
224 Dimensions

Readers on

mendeley
256 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance data
Published in
Arthritis Research & Therapy, May 2019
DOI 10.1186/s13075-019-1882-2
Pubmed ID
Authors

A. Deodhar, P. J. Mease, I. B. McInnes, X. Baraliakos, K. Reich, A. Blauvelt, C. Leonardi, B. Porter, A. Das Gupta, A. Widmer, L. Pricop, T. Fox

X Demographics

X Demographics

The data shown below were collected from the profiles of 16 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 256 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 256 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 26 10%
Student > Master 26 10%
Other 22 9%
Student > Bachelor 21 8%
Student > Ph. D. Student 16 6%
Other 42 16%
Unknown 103 40%
Readers by discipline Count As %
Medicine and Dentistry 72 28%
Pharmacology, Toxicology and Pharmaceutical Science 17 7%
Nursing and Health Professions 10 4%
Immunology and Microbiology 10 4%
Biochemistry, Genetics and Molecular Biology 9 4%
Other 30 12%
Unknown 108 42%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 33. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 October 2021.
All research outputs
#1,200,224
of 25,385,509 outputs
Outputs from Arthritis Research & Therapy
#112
of 3,381 outputs
Outputs of similar age
#27,021
of 363,257 outputs
Outputs of similar age from Arthritis Research & Therapy
#7
of 63 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,381 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.2. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 363,257 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 63 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.